LOUISVILLE, Ky.--(BUSINESS WIRE)--
As previously disclosed, Humana Inc. (HUM) will be hosting an Investor Meeting in New York City on Tuesday, March 19, 2019, at 8:30 a.m. eastern time. The Investor Meeting will include a number of presentations by company leaders focusing on Humana’s strategic direction, operational and financial progress as well as expectations for future performance.
Humana encourages the investing public and media to listen to its Investor Meeting via the Internet since attendance at the event is by invitation only. The Investor Meeting webcast and virtual presentation may be accessed via Humana’s Investor Relations page at humana.com. The company suggests web participants sign on approximately 15 minutes in advance of the event. The company also suggests web participants visit the site in advance to run a system test and to download any free software needed.
For those unable to participate in the live event, the replay will be available in the Historical Webcasts and Presentations section of the Investor Relations page at humana.com approximately 4 hours following the live webcast.
Financial Guidance Update
For the year ended December 31, 2019 (FY 2019), Humana’s management expects to reaffirm its Generally Accepted Accounting Principles (GAAP) guidance range of approximately $16.60 to $17.10 in diluted earnings per common share (EPS), or approximately $17.00 to $17.50 in adjusted earnings per common share (Adjusted EPS). This guidance is consistent with the guidance reaffirmed in Humana’s Form 8-K filing dated February 28, 2019.
Adjusted EPS should be considered in addition to, but not as a substitute for, or superior to, GAAP EPS. A reconciliation of GAAP EPS to Adjusted EPS follows:
|Diluted earnings per common share||FY 2019 Guidance|
|GAAP||~$16.60 to $17.10|
|Amortization of identifiable intangibles||0.40|
|Adjusted (non-GAAP) – FY 2019 projected||~$17.00 to $17.50|
The company has included Adjusted EPS in this release, a financial measure that is not in accordance with GAAP. Management believes that this measure, when presented in conjunction with the comparable measure of GAAP EPS, is useful to both management and its investors in analyzing the company's ongoing business and operating performance. Consequently, management uses Adjusted EPS as an indicator of the company's business performance, as well as for operational planning and decision making purposes.
Humana Inc. (HUM) is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.
To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience that makes health care easier to navigate and more effective.
More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:
- Annual reports to stockholders
- Securities and Exchange Commission filings
- Most recent investor conference presentations
- Quarterly earnings news releases and conference calls
- Calendar of events
- Corporate Governance information